Interleukin 12 is a heterodimeric molecule that serves as a potent co-stimulator enhancing the development of Thl cells. As one of the classical Thl cell-mediated responses is contact sensitivity in skin, we wondered whether IL-12 might be produced by epidermal cells and serve as a mediator of this immune response. Using a sensitive, quantitative PCR technique we demonstrate that p35 chain mRNA of IL-12 is produced constitutively by human epidermal cells, whereas p40 chain mRNA can only be detected in epidermis treated with contact allergen, but not epidermis exposed to irritants or tolerogens. Time course studies showed a dramatic induction of IL-12 p40 mRNA 4 h after in vivo allergen treatment reaching peak strength after 6 h. In cell depletion assays we show that epidermal keratinocytes are the major source of this cytokine in the epidermis. This was further supported by analysis of mRNA derived from the human keratinocyte cell line HaCat expressing IL-12 p35 and p40 mRNA upon stimulation. The presence of bioactive IL-12 in supernatants derived from allergen-stimulated epidermal cells was demonstrated by IL-12-specific bioassay. Additional evidence for the functional importance of IL-12 in primary immune reactions in skin was obtained in allogeneic proliferation assays using human haptenated epidermal cells containing Langerhans cells as APC and allogeneic CD4+ T cells as responders. Anti-IL-12 mAb inhibited the proliferation of T cells by 50%. In aggregate our data demonstrate that nonlymphoid keratinocytes are capable of producing functional IL-12 and provide evidence for the functional significance of IL-12 in primary immune responses in skin. (J. Clin. Invest. 1994. 94:1799-1805
Introduction
Contact sensitivity has served as a classical model for Th cellmediated primary immune responses in skin for a long time. Since the early studies by Landsteiner, Chase, and Macher (1) (2) (3) elucidated that contact allergy was a T cell-mediated response where the allergen had to be moved to the regional lymph node to initiate sensitization, a lot of knowledge has been accumulated about the cells and the molecules involved in the sensitization process. The current concept for the sensitization process is that haptens that serve as allergens when applied to skin bind to peptides attached to MHC molecules on epidermal Langerhans cells (LC)' as the APC of the epidermis (4) . These cells belong to the dendritic cell system and are capable of inducing primary immune responses (5, 6 ). Aiba and Katz (7) demonstrated that after contact with allergens LC become functionally activated, upregulate their MHC class II molecules and become more potent accessory cells. Kripke et al. (8) demonstrated that these LC migrate to regional lymph nodes probably to activate naive T cells.
Our own group has recently defined the cytokines involved in the early induction phase of contact sensitivity that help LC to become more potent APC. We defined a cytokine profile specific for allergens that was not detected when irritants or tolerogens were applied to the skin (9) . Furthermore we showed that LC-derived IL-1 j3 not only was the first cytokine to be induced after hapten application but also was essential for the induction of a sensitization, as injection of an anti-IL-l1, mAb before application of allergen completely prevented epidermal sensitization (10) . Since Mosmann and co-workers (11, 12) defined the existence of two distinct T helper cell subsets it is known that T lymphocytes which are required for both cellmediated immune responses or the production of antibody by B lymphocytes, are composed of two distinct subsets-T helper 1 cells producing IL-2 and IFN-y execute cell-mediated immune reactions, whereas Th2 cells producing IL-4, IL-5, IL-6, and IL-10 assist in antibody production for humoral immunity. The mechanisms, however, by which a particular T cell lineage is steered down the path towards a Th 1 or Th2 fate have remained unclear.
Lately, the novel cytokine IL-12 (originally called "natural killer cell stimulatory factor" or "cytotoxic lymphocyte maturation factor") has evolved as a major player in the regulation of this homeostasis (13, 14) . IL-12 is a heterodimeric molecule composed of two covalently linked chains, p40 and p35 (15, 16) . The two chains are linked to form a biologically active 70-kD dimer, whereas no IL-12-like biological activity is mediated by either recombinant chain separately (17) . Whereas the p35 chain of IL-12 is expressed by numerous, including nonlymphoid, tissues, expression of p40 was thought to be restricted to the lymphoid cell system (16, (18) (19) . IL-12 was originally identified as a product of B lymphoblastoid cell lines enhancing specific cytolytic T cell responses and inducing NK cell cytotoxic activity (13, 14) . In the meantime IL-12 was shown to be produced by monocytes and B cells triggering the production of IFN-y by NK and T cells and thereby helping to select Thltype immune responses and initiating cell-mediated immunity (20) (21) (22) (23) (24) (25) . Additionally IL-12 has been shown to augment proliferation of certain T lymphocytes (26, 27) and to have antitumoral activities in mice (28 PCR and liquid hybridization. PCR and liquid hybridization were performed as described previously (9) . Briefly, total cellular RNA was extracted by RNAzol B following the instructions of the manufacturer. Extraction was followed by spectrophotometric quantitation and 25 cycles RT-PCR as described, using the (30) . Briefly, the anti-human IL-12 mAb 2-4A1 (kindly provided by Dr. Maurice Gately, HofmannLaRoche Inc., Nutley, NJ) was absorbed (2,5 jig/ml, 100 III/well, in sodium carbonate buffer, pH 9.6) overnight at 4°C to sterile 96-well ELISA plates (Maxisorp, Nunc-Immunoplate, Nunc GmbH, Wiesbaden, Germany). The plates were shook out and blocked with 0.5% BSA in PBS (200 jl, 1 h, room temperature). After three washes with distilled water, dilutions of rhIL-12 standard (kindly provided by Dr. Maurice Gately, Hofmann-LaRoche Inc.) or supernatant fluids to be tested were added (100 Al/well, 3 h, room temperature). The plates were washed five times again and human PHA stimulated lymphoblasts (PBMC stimulated with PHA for 3 d and rhIL-2 for 1 d) were added (2 X 104/well, 100 ,u/well). After 48 h incubation (37°C, 5% CO2), proliferation was measured by incorporation of [3H]Thymidine (1 pCi/well for 6 h). A standard curve was plotted and IL-12 contents of samples was calculated. In some experiments samples were preincubated with rat antihuman anti-IL-12 mAb 2-4A1 at 10 tg/ml (kindly provided by Dr.
M. K. Gately).
Allogeneic proliferation assay. EC suspensions were prepared as described above and either stimulated with TNBS or left unstimulated. Allogeneic CD4+ T cells were prepared from blood of healthy normal volunteers by Ficoll density centrifugation. Afterwards interface cells were stained with anti-CD4 mAb (Becton Dickinson) and positively enriched by anti-mouse IgG-coated paramagnetic beads (Dynal, Hamburg, FRG). As assessed by inverted phase immunofluorescence microscopy, cells were > 95% pure CD4+. Afterwards T cells were cocultured with EC for 4 d in the presence or absence of anti-IL-12 mAb or control mAb. [3H]Thymidine was added at 1 yCi for the last 12 h.
Results
Induction of IL-12 mRNA in human epidermis. 3% TNCB was applied to skin of human healthy volunteers after informed consent. Skin punch biopsies were obtained after various time points (0-48 h) after application of the allergen. Afterwards EC suspensions were prepared as described and total epidermal RNA was extracted by RNAzol B immediately. RNA was quantitated by spectrometric analysis and subjected to 25 cycles of RT-PCR followed by liquid hybridization. Signals for p35, p40, and /3-actin control were detected by autoradiography (Fig. 1) . 1800 Muller et al. (Fig. 2) . These data indicate that IL-12 p40 chain is selectively induced by contact allergen in our test system.
Cell depletion assays. EC suspensions were prepared as described in Methods and stimulated with TNBS (a water-soluble analogue of TNCB) as described. Afterwards EC suspensions were treated with either anti-HLA-DR mAb or CD4/CD8 mAb or an unrelated control mAb followed by treatment with low tox complement to deplete LC or T cells, respectively. Afterwards aliquots were stained again with the respective mAb and subjected to FACScan analysis to control for cell depletion. The remaining cells were lysed immediately by RNAzol B for RNA extraction and subjected to PCR analysis for expression of p35, p40, and fi-actin (Fig. 3) To further support this finding, the immortalized human keratinocyte cell line HaCat was cultured as described and treated with PDB (a phorbolester). After RNA extraction and PCR analysis, p35, p40, andl/-actin signals were sought. Again p35 chain mRNA signals were expressed constitutively, whereas only PDB-treated HaCat cells expressed mRNA signals for p40 (Fig. 4) . ,/-actin controls remained unaffected. Our data indicate that human keratinocytes are capable of producing IL-12 mRNA. It should be noted however that stimulation of HaCat cells with the soluble allergen TNBS alone did not result in induction of p40 chain mRNA. p40 chain could be induced in those cells by addition of IL-13 at 50 ng/ml (but not TNF-a) for 6 h (Fig. 5) as has been shown for most other allergenspecific cytokines before (10 (Fig. 7) . Our data indicate that IL-12 is of functional importance for the induction of human T cell proliferation by epidermal LC in the induction of primary immune responses and that the enhanced proliferation of allogeneic T cells towards haptenated EC may be due to release of IL-12 by keratinocytes after hapten application. (31) . Thus for promoting ThI development DC's and a bystander cell producing IL-12 are required. Our own laboratory has recently been involved in characterizing the early molecular events in the induction phase of contact sensitivity (9) . In prior studies we showed that the early induction phase of this primary immune reaction in skin is characterized by a distinct and specific pattern of epidermal cytokines that only occurs after application of allergen, not tolerogen or irritant (9) . The earliest cytokine to be induced by allergen in this cytokine cascade is LC-derived IL-1p.. The signal for this cytokine is found to be expressed within 15 min after application of allergen. Further functional studies demonstrated that IL-18 injection into skin mimicks the changes in LC morphology and function usually caused by allergen, as well as inducing a cytokine pattern identical to the one caused by epicutaneous application of allergen (10) . In addition, injection of anti-IL-1,6-specific mAb before application of allergen completely prevented epicutaneous sensitization (10) . Taken together our data indicate that LC-derived IL-1p6 seems to be the essential cytokine in contact sensitivity.
Further studies demonstrated that as a second important cytokine IL-10 seemed to be involved in controlling the inflammatory process of allergic contact dermatitis (32) . Whereas IL-1I3 was produced within 15 min of hapten application, IL-10 was produced by epidermal keratinocytes late in the induction phase of contact sensitivity with signals reaching peak strength 12 h after hapten painting (32) . Functional studies showed that IL-1O not only inhibited IFN-y and IL-2 production in LC-induced proliferation assays, but also inhibited LC accessory cell function by preventing the induction of membranebound costimulatory molecules on LC (33) . Treatment The finding that IL-12 is produced by human keratinocytes after stimulation with allergen is especially interesting with regard to the data demonstrating that 1L-12 seems to be a powerful mediator for a Thl type differentiation of T helper cells in vitro and in vivo. The influence of IL-12 on T cell development is believed to be exerted on the level of the T cell directly (24, 25) . However it is believed that LC/T cell interactions take place in the regional lymph node (8) . At first glance it appears to be a contradiction that IL-12 produced in skin can influence an immune response taking place in the lymph node. There are several possible explanations. The easiest possibility is that keratinocyte-derived IL-12 is being released and washed away by lymph fluids to the draining regional lymph node during the induction phase of contact sensitivity, where it could directly influence the priming of naive T cells by, for example, LC. Especially for a very potent cytokine such as IL-12 that has been shown to be effective in picogram amounts this mechanism is very feasible.
Another possibility is that there might be an (indirect) effect of IL-12 on APC such as LC. In fact Seder et al. (34) showed recently that IL-12 in an APC-independent system using anti-CD3 mAb as a stimulus with naive CD4' T cells as responders enhanced Thl development-an effect that was blocked by simultaneous addition of anti-IFN'y mAb. However, in an APCdependent assay using splenic accessory cells and naive CD4' T cells as responders, anti-IFNy mAb did not significantly inhibit IL-12 triggered Thl differentiation (34). These data suggest that either IL-12 together with IFN-y or IL-12 and an APCderived additional signal induce Thl differentiation. One could speculate that under circumstances where IL-12 is produced in the presence of an APC, this APC is (indirectly) modified by IL-12 to a phenotype promoting Thl differentiation. In skin this might mean that keratinocyte-derived IL-12 "primes" LC towards a Thl-inducing APC.
Additionally although most immunodermatologists believe that the priming of T cells by LC takes place in the regional lymph node, nobody knows whether this is the exclusive mechanism. It is known for some time that even in normal epidermis there are small amounts of CD4' T cells that would be a possible target for IL-12 action. Finally, during inflammatory reactions of the skin numerous T cells are attracted to the epidermis where they might be influenced by keratinocyte-derived IL-12 to differentiate towards a ThI phenotype.
Of further interest is also the seemingly intricate balance of cytokine production in the epidermis. Apart from the essential inducing function of LC-derived IL-1,/3, production of IL-12 during earlier phases of primary immune responses might be controlled by the release of IL-10 during later phases, as has been demonstrated in other systems. This effect could subserve the function of a balancing mechanism avoiding dominance of a particular type of immune reaction that might be harmful to the organism. Furthermore, it cannot be ruled out that production of IL-12 p40 chain (that was shown to inhibit IL-12 activity) (35) may be so dominant at later phases of the immune reaction as to suppress the biologic effects of IL-12 heterodimer. Further studies are needed to exactly define the induction and mechanisms of directing primary immune responses in skin.
